Merck Ragweed Pollen Allergy Drug heading for approval

See on Scoop.itSTEFANO DONNO GLOBAL NEWS

January 28, 2014: Allergenic Products Advisory Committee Meeting will discuss safety and efficacy of RAGWITEK, a short ragweed pollen allergen extract tablet for sublingual use, manufactured by Merck, indicated for immunotherapy for diagnosed ragweed pollen induced allergic rhinitis, with or without conjunctivitis.

 

FDA review documents posted online consider the drug safe and effective. 

See on www.fda.gov

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s